Oculis Holding AG (OCS) Accumulated Expenses (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Accumulated Expenses came in at $23.5 million in Q1 2026, up 6.43% year-on-year from $22.1 million in Q1 2025, and down 5.89% quarter-over-quarter from $25.0 million in Q4 2025.

Oculis Holding AG (OCS) Accumulated Expenses (2021 - 2026) Analysis & Trends

Oculis Holding AG's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $23.5 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 6.43% year-over-year to $23.5 million in Q1 2026; TTM through Mar 2026 was $23.5 million, a 6.43% increase from a year earlier, with the FY2025 full-year figure at $24.1 million, up 16.42% from the prior year.
  • Accumulated Expenses slipped to $23.5 million in Q1 2026 per OCS's latest filing, from $25.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $25.0 million in Q4 2025 and bottomed at $6.7 million in Q4 2023.
  • The 5-year median for Accumulated Expenses is $17.0 million (2024), against an average of $16.6 million.
  • Across the five-year window, Accumulated Expenses dropped 19.36% in 2023 and jumped 209.8% in 2024, its largest moves.
  • Year by year, Accumulated Expenses stood at $8.3 million in 2022, then declined by 19.36% to $6.7 million in 2023, then soared by 209.8% to $20.8 million in 2024, then rose by 20.26% to $25.0 million in 2025, then retreated by 5.89% to $23.5 million in 2026.
  • Per Business Quant, the three latest OCS Accumulated Expenses figures stand at $23.5 million (Q1 2026), $25.0 million (Q4 2025), and $24.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.51 Mn
Dec 31, 2025 24.98 Mn
Sep 30, 2025 24.93 Mn
Jun 30, 2025 24.06 Mn
Mar 31, 2025 22.09 Mn
Dec 31, 2024 20.77 Mn
Sep 30, 2024 16.97 Mn
Jun 30, 2024 14.11 Mn
Mar 31, 2024 9.58 Mn
Dec 31, 2023 6.71 Mn
Sep 30, 2023 9.83 Mn
Jun 30, 2023 9.35 Mn
Dec 31, 2022 8.32 Mn
Dec 31, 2021 3.30 Mn